Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04915079 · ClinicalTrials.gov registry record · Phase 1
PRISM Race and Communication Pilot RCT
A Phase 1 study, sponsored by University of Washington.
- Completed
- Registry status
- Phase 1
- Development phase
- 28
- Enrollment target
NCT04915079 is a Phase 1 study that has completed, run by University of Washington. The registered enrollment target is 28 participants.
The verdict
NCT04915079, a Phase 1 study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 28 participants
- Enrollment target
Study Summary
This is a pilot randomized trial of 60 patients to test feasibility, acceptability and efficacy of PRISM to improve resilience and facilitate improved patient-clinician communication in racially minorities patients with serious illness.
Interventions
- BEHAVIORAL Promoting Resilience in Stress Management (PRISM)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2023-07-19 |
| Est. Completion | 2025-08-29 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04915079
The ClinicalTrials.gov registry entry for NCT04915079 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Promoting Resilience in Stress Management (PRISM) is the first listed.
NCT04915079 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04915079 about?
NCT04915079 is a clinical study titled "PRISM Race and Communication Pilot RCT". This is a pilot randomized trial of 60 patients to test feasibility, acceptability and efficacy of PRISM to improve resilience and facilitate improved patient-clinician communication in racially minorities patients with serious illness.
What is the current status of trial NCT04915079?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 28 participants. The study started on 2023-07-19. Estimated completion is 2025-08-29.
What interventions are being tested in trial NCT04915079?
The interventions under investigation include: Promoting Resilience in Stress Management (PRISM) (BEHAVIORAL).
Who is sponsoring clinical trial NCT04915079?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.